Skip to main content
. 2022 Aug 12;14(8):1676. doi: 10.3390/pharmaceutics14081676

Figure 3.

Figure 3

Imatinib daily dose over the 12-month adaptation period for the patients included in the TDM arm (A), the control arm (B) and the observational arm (C). The violin plots represent the distributions of individual daily doses.